With its current capacity, the company can supply 50,000 to 95,000 pieces of the injectable per month
Daman-based Sovereign Pharma announced the despatch of its first batch of Remdesivir injections for Cipla. Within the union territory of Daman and Diu, one of India’s pharmaceutical hubs, Sovereign Pharma has prepared the first batch of Remdesivir within record time. Under the guidance of the administrator Praful Patel, the facility recently went through a meticulous inspection by the CDSCO and received necessary approvals from the authority within a week.
To commemorate the achievement, Anil Kumar Singh, Advisor to the Administrator, Dr AM Muthamma, Secretary, Health and Family Welfare, Dr Rakesh Minhas, Collector, Daman, Dr Vikramjit Singh, SP Daman, Dr Das, Director, Medical and Health Services & Drug Licensing Authority, and Dr Agarwal, Drug Inspector were present along with Kairus Dadachanji, MD and Rishad Dadachanji, Director, Sovereign Pharma to flag off the first dispatch of Remdesivir from the Daman facility.
“Our manufacturing sites remain compliant with the highest global standards and certifications at all times, as it is our constant endeavour to cater to the ever-evolving requirements of the pharma industry. Even in such unprecedented times, we are proud that our facility has been able to supply this medication in record time to one of our key clients,” shared Rishad Dadachanji.